SCHEMBL30906532

SCHEMBL30906532

CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)CC

nearest known ligand 0.71

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 18/20 0.71
▸ ECE1 P42892 1/20 0.63
▸ MUS81 Q96NY9 1/20 0.63
▸ CCKBR P32239 1/20 0.61
▸ IL23R Q5VWK5 1/20 0.60
▸ KISS1R Q969F8 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30906511 1.00 GLP1R (0.71) GLP1RECE1MUS81CCKBRIL23R
SCHEMBL31000949 0.98 GLP1R (0.75) GLP1RECE1MUS81CCKBR
SCHEMBL30906503 0.98 GLP1R (0.72) GLP1RECE1MUS81CCKBR
SCHEMBL30906555 0.98 GLP1R (0.68) GLP1RECE1MUS81CCKBRIL23R
SCHEMBL30906493 0.98 GLP1R (0.70) GLP1RECE1MUS81CCKBRIL23R
SCHEMBL30906486 0.97 GLP1R (0.70) GLP1RECE1MUS81CCKBRIL23R
SCHEMBL30906510 0.97 GLP1R (0.67) GLP1RECE1MUS81CCKBRIL23R
SCHEMBL30906465 0.97 GLP1R (0.72) GLP1RECE1MUS81IL23R
SCHEMBL30906516 0.97 GLP1R (0.72) GLP1RECE1MUS81IL23R
SCHEMBL30906536 0.96 GLP1R (0.71) GLP1RECE1MUS81IL23R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598964-A2 ANTI-IGE ANTIBODIES Abwiz Bio, Inc. (US) 2025-08-13 — — EP disclosed
US-20240182599-A1 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. 2024-06-06 — — US disclosed
WO-2024076785-A2 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. (US) 2024-04-11 — — WO disclosed
Send feedback